Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
A Phase 2, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Safety, Tolerability and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo as Add-On Therapy in Symptomatic Subjects With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
1524
mi
from 91732
Rochester, MN
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
A Phase 2, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Safety, Tolerability and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo as Add-On Therapy in Symptomatic Subjects With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
A Phase 2, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Safety, Tolerability and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo as Add-On Therapy in Symptomatic Subjects With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
2434
mi
from 91732
New York, NY
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
A Phase 2, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Safety, Tolerability and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo as Add-On Therapy in Symptomatic Subjects With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medical Center
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
A Phase 2, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Safety, Tolerability and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo as Add-On Therapy in Symptomatic Subjects With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
2033
mi
from 91732
Cleveland, OH
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
A Phase 2, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Safety, Tolerability and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo as Add-On Therapy in Symptomatic Subjects With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
University Hospitals at Case Medical Center
2033
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
A Phase 2, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Safety, Tolerability and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo as Add-On Therapy in Symptomatic Subjects With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
1189
mi
from 91732
Calgary,
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
A Phase 2, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Safety, Tolerability and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo as Add-On Therapy in Symptomatic Subjects With Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Peter Lougheed Center
1189
mi
from 91732
Calgary,
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated:  12/31/1969
1527
mi
from 91732
Iowa City, IA
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
University of Iowa
1527
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated:  12/31/1969
1965
mi
from 91732
Detroit, MI
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Wayne State University
1965
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated:  12/31/1969
648
mi
from 91732
Albuquerque, NM
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
648
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated:  12/31/1969
2244
mi
from 91732
Rochester, NY
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
University of Rochester
2244
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated:  12/31/1969
2203
mi
from 91732
Durham, NC
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Duke University
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated:  12/31/1969
1962
mi
from 91732
Columbus, OH
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
The Research Institute at Nationwide Children's Hospital
1962
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated:  12/31/1969
2562
mi
from 91732
Providence, RI
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
2562
mi
from 91732
Providence, RI
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated:  12/31/1969
1777
mi
from 91732
Birmingham, AL
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated:  12/31/1969
25
mi
from 91732
Los Angeles, CA
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated:  12/31/1969
329
mi
from 91732
Palo Alto, CA
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Stanford University
329
mi
from 91732
Palo Alto, CA
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated:  12/31/1969
1221
mi
from 91732
Dallas, TX
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
1221
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
329
mi
from 91732
Palo Alto, CA
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
Stanford University
329
mi
from 91732
Palo Alto, CA
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
818
mi
from 91732
Denver, CO
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
University of Colorado at Denver
818
mi
from 91732
Denver, CO
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
2281
mi
from 91732
Washington,
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
George Washington University
2281
mi
from 91732
Washington,
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
2135
mi
from 91732
Jacksonville, FL
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
2135
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
1511
mi
from 91732
Minneapolis, MN
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
2035
mi
from 91732
Cleveland, OH
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
2035
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
2036
mi
from 91732
Cleveland, OH
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
2119
mi
from 91732
Pittsburgh, PA
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
University of Pennsylvania
2119
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
572
mi
from 91732
Salt Lake City, UT
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
University of Utah
572
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
961
mi
from 91732
Seattle, WA
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
2125
mi
from 91732
Winston-Salem, NC
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
Wake Forest University
2125
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
2119
mi
from 91732
Pittsburgh, PA
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
University of Pittsburg
2119
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
1922
mi
from 91732
Atlanta, GA
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Children's Heathcare of Atlanta, Inc. at Egleston
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
1961
mi
from 91732
Columbus, OH
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
1961
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
2375
mi
from 91732
Philadelphia, PA
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
2452
mi
from 91732
Montreal,
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
2452
mi
from 91732
Montreal,
Click here to add this to my saved trials
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
825
mi
from 91732
Aurora, CO
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
1793
mi
from 91732
Indianapolis, IN
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Riley Hospital for Children
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients
Effects of Nebivolol on Microvascular Perfusion in the Skeletal Muscles During Exercise in Hypertensive Patients
Status: Enrolling
Updated:  12/31/1969
1225
mi
from 91732
Dallas, TX
Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients
Effects of Nebivolol on Microvascular Perfusion in the Skeletal Muscles During Exercise in Hypertensive Patients
Status: Enrolling
Updated: 12/31/1969
U.T. Southwestern Medical Center
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients
Effects of Nebivolol Versus Metoprolol on Blood Flow Responses to Exercise and Angiotensin II in Hypertensive Patients
Status: Enrolling
Updated:  12/31/1969
1225
mi
from 91732
Dallas, TX
Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients
Effects of Nebivolol Versus Metoprolol on Blood Flow Responses to Exercise and Angiotensin II in Hypertensive Patients
Status: Enrolling
Updated: 12/31/1969
U.T. Southwestern Medical Center
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Preeclampsia: A Marker for Future Cardiovascular Risk in Women
Preeclampsia: A Marker for Future Cardiovascular Risk in Women
Status: Enrolling
Updated:  12/31/1969
2578
mi
from 91732
Boston, MA
Preeclampsia: A Marker for Future Cardiovascular Risk in Women
Preeclampsia: A Marker for Future Cardiovascular Risk in Women
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)
Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure
Status: Enrolling
Updated:  12/31/1969
2035
mi
from 91732
Cleveland, OH
PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)
Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
2035
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Status: Enrolling
Updated:  12/31/1969
2189
mi
from 91732
CHapel Hill, NC
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Status: Enrolling
Updated: 12/31/1969
UNC Chapel Hill
2189
mi
from 91732
CHapel Hill, NC
Click here to add this to my saved trials
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Status: Enrolling
Updated:  12/31/1969
2203
mi
from 91732
Durham, NC
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
364
mi
from 91732
Sacramento, CA
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Regional Cardiology Associates
364
mi
from 91732
Sacramento, CA
Click here to add this to my saved trials
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
1332
mi
from 91732
Kansas City, KA
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
1332
mi
from 91732
Kansas City, KA
Click here to add this to my saved trials
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
2578
mi
from 91732
Boston, MA
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
2578
mi
from 91732
Boston, MA
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
2184
mi
from 91732
Charleston, SC
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
2184
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
2481
mi
from 91732
New York, NY
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
2481
mi
from 91732
New York, NY
Click here to add this to my saved trials
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
mi
from 91732
Prague,
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Na Homolce Hospital
mi
from 91732
Prague,
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
342
mi
from 91732
Phoenix, AZ
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Arizona Pulmonary Specialists, Ltd.
342
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
427
mi
from 91732
Tucson, AZ
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
University of Arizona
427
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
212
mi
from 91732
Fresno, CA
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
University of California San Francisco-Fresno
212
mi
from 91732
Fresno, CA
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated:  12/31/1969
13
mi
from 91732
Los Angeles, CA
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials